George Sopko

Medical Officer and Program Director at National Institutes of Health (NIH)
📚 Program director at NIH | Bethesda, Maryland, United States
Mutual Connections
Loading...
S9-012025-1808532
0 Publications
0 Followers
0 Following
0 Questions

👤 About

Skills & Expertise

Evidence Based Medicine

Research Interests

Clinical Research Clinical Trials cardiology internal medicine

Connect With Me

💼 Experience

Medical Officer and Program Director

National Institutes of Health (NIH) · January 1987 - Present
  • program director of clinical trials involving international cooperation and workshops designed to evaluate current state of knowledge; responsibility for the planning, development, direction, coordination, and conduct of basic, applied, and clinical research in areas of cardiovascular disease and for promoting efforts to enhance knowledge of the etiology and pathophys¬i¬ology of heart disease and to improve methods of diagnosis, treatment and prevention of these diseases; and participating in the formulation of policies pertaining to the establishment of priorities in the context of needs and opportunities based on domestic and international activities in the field to develop pioneering programs to meet national needs. Major program responsibilities have included Clinical Research Consortium to Improve Resuscitation Outcomes Consortium (ROC), Surgical Treatment of Congestive Heart Failure (STICH) trial, Treatment Of Preserved Cardiac function heart failure with an Aldosterone antagonist (TOPCAT) trial, Heart Failure Clinical Research Network, Occluded Artery Trial (OAT) trial, Arrhythmogenic Right Ventricular Dysplasia (ARVD) study, Bypass Angioplasty Revascularization Investigation in Diabetes (BARI 2D) trial, Bypass Angioplasty Revascularization Investigation (BARI) trial, Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) Trial, Women’s Ischemic Syndrome Evaluation (WISE) Study, Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted Human Immunodeficiency Virus Infection (P2C2) Study, Asymptomatic Myocardial Ischemia Pilot (ACIP) Trial, Coronary Artery Surgery Study (CASS), Balloon Valvuloplasty Registry (BVR), Thrombolysis In Myocardial Infarction (TIMI II), and Catheter Ablation Registry (CAR).
dd